APA (7th ed.) Citation

Z, F., S, B., L, B., V, M., M, A., C, B., . . . E, E. Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events. Dove Medical Press.

Chicago Style (17th ed.) Citation

Z, Fratton, Bighetti S, Bettolini L, Maione V, Arisi M, Buligan C, Stinco G, and Errichetti E. Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events. Dove Medical Press.

MLA (9th ed.) Citation

Z, Fratton, et al. Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events. Dove Medical Press.